2021年最新SCI期刊影响因子查询系统
Expert Opinion On Drug Safety 期刊详细信息
基本信息
期刊名称 | Expert Opinion On Drug Safety Expert Opinion On Drug Safety |
---|---|
期刊ISSN | 1474-0338 |
期刊官方网站 | http://www.tandfonline.com/loi/ieds20#.V48bfkz9cSQ |
是否OA | 否 |
出版商 | Taylor and Francis Ltd. |
出版周期 | Bimonthly |
始发年份 | 2002 |
年文章数 | 119 |
最新影响因子 | 4.011(2021) |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学3区 | PHARMACOLOGY & PHARMACY 药学3区 | 否 | 是 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 3.10 | 1.007 | 0.977 |
Medicine Pharmacology (medical) |
50 / 232 | 78% |
补充信息
自引率 | 2.00% |
---|---|
H-index | 57 |
SCI收录状况 |
Science Citation Index Expanded |
官方审稿时间 | |
网友分享审稿时间 | 数据统计中,敬请期待。 |
PubMed Central (PML) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1474-0338%5BISSN%5D |
投稿指南
期刊投稿网址 | https://mc.manuscriptcentral.com/eods |
---|---|
收稿范围 | Expert Opinion on Drug Safety (ISSN 1474-0338 [print], 1744-764X [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on all aspects of drug safety and original papers on the clinical implications of drug treatment safety issues, providing expert opinion on the scope for future development. The Editors welcome: Reviews covering occurrence, management and prevention of drug-associated adverse events; risk-benefit analyses of individual drugs and drug classes; safety in 'at-risk' patient populations; comparative tolerability studies; pharmacovigilance and pharmacoepidemiological studies Drug Safety Evaluations reviewing the safety data on a particular drug Original Research papers reporting the results of post-marketing surveillance and other safety studies looking at specific drugs, populations and outcomes; methods for the detection and evaluation of drug-associated adverse events The audience consists of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in monitoring drug safety. |
收录体裁 | |
投稿指南 | |
投稿模板 | |
参考文献格式 | |
编辑信息 |